Join this free webinar to learn how you can avoid animal testing and accelerate time to market by using results from in vitro testing for the endpoints of cytotoxicity, skin […]
Join this free webinar where Ron Brown, toxicologist and former FDA risk assessor, will outline the need for a new and more agile approach for the biological safety assessment of […]
This two days hands-on training is hosted by acCELLerate. Skin sensitization is a complex systemic process and since several years, methods to replace animal tests have been validated and adopted […]
Biocompatibility for Medical Devices Tuesday, 20 June 2023 12:00 - 12:30 The GARDskin Medical Device assay for assessing the skin sensitizing potential of medical devices: A case study on the use of […]
12th World Congress on Alternatives and Animal Use in the Life Sciences Our team and partners will feature the GARD® assays in several posters and presentations. Join us to explore […]
New opportunities for skin sensitization testing with GARD®skin OECD TG 442E Come meet us at booth #36 and join our poster presentations to learn how the high performance and broad […]
Dermal Sensitizers: A Workshop on State of the Science and Utilization of New Approach Methodologies for Quantitative Risk Assessment
We invite you to participate in our webinar where new cutting edge GARD results will be explained by the experts at SenzaGen and our partners. In case you missed SenzaGen’s […]
→ Booth #333 Spotlight on difficult-to-test samples and in vitro quantitative potency assessment as an alternative to the Local Lymph Node Assay Come meet us at booth #333 and join our […]
